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Background: Obesity is a major public health problem in many poor countries where micronutrient deficiencies
are prevalent. A partial meal replacement may be an effective strategy to decrease obesity and increase
micronutrient intake in such populations. The objective was to evaluate the efficacy of a partial meal replacement
with and without inulin on weight reduction, blood lipids and micronutrients intake in obese Mexican women.
Methods: In a randomized controlled clinical trial 144 women (18–50 y) with BMI≥ 25 kg/m2, were allocated into
one of the following treatments during 3 months: 1) Two doses/d of a partial meal replacement (PMR), 2) Two
doses/d of PMR with inulin (PMR + I) , 3) Two doses/d of 5 g of inulin (INU) and 4) Control group (CON). All groups
received a low calorie diet (LCD). Weight, height, hip and waist circumference were measured every 2 weeks and
body composition, lipids and glucose concentration and nutrient intake were assessed at baseline and after
3 months.
Results: All groups significantly reduced weight, BMI, waist and hip circumference. Differences between groups
were only observed in BMI and weight adjusted changes: At 45 days PMR group lost more weight than INU and
CON groups by 0.9 and 1.2Kg, respectively. At 60 days, PMR+ I and PMR groups lost more weight than in INU by
0.7 and 1Kg, respectively. Subjects in PMR, PMR+ I and INU significantly decreased triglycerides. Energy intake was
reduced in all groups. Fiber intake increased in PMR + I and INU groups. Some minerals and vitamins intakes were
higher in PMR and PMR+ I compared with INU and CON groups.
Conclusion: Inclusion of PMR with and without inulin to a LCD had no additional effect on weight reduction than
a LCD alone but reduced triglycerides and improved intake of micronutrients during caloric restriction. PMR could
be a good alternative for obese populations with micronutrient deficiencies.
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The prevalence of obesity is increasing in many countries
and has become a public health challenge in populations
worldwide. It is estimated that at least one billion of
individuals worldwide are overweight (body mass index,
BMI≥ 25 kg/m2) and at least 300 million are obese
(BMI≥ 30 kg/m2) [1,2]. The prevalence of obesity has
specially increased in populations in developing coun-
tries; for example, a recent survey carried out in Mexico
found that the prevalence of obesity in adults in 2006
was 24.2% in men and 34.5% in women, increasing 4%
in only 6 years [3,4].
Recent studies have suggested that micronutrient defi-
ciencies might be associated with a higher susceptibility
for obesity which might partially explain why obesity in
poor countries has increased more rapidly [5]. The pos-
sible association of some micronutrient deficiencies with a
higher susceptibility for fat deposition and obesity has
recently been revised [6]. Since calorie restricted diets
might worsen micronutrient deficiencies, a strategy to re-
duce calories in obese population with a high probability
of having some micronutrient deficiencies, should con-
template increasing the intake of vitamins and minerals.
Low calorie diets (LCD) and an increase in physical
activity are effective strategies to reduce body fat and to
control body weight [7]; however a high proportion of
individuals trying to lose weight find it very difficult to
reduce energy intake [8]. Partial meal replacements
(PMR) are single food or selection of foods intended as
replacement of one or two daily meals to reduce energy
intake. PMR are made with variety of food preparations,
they can be liquid or powder formulas, frozen foods or
bars fortified, all fortified with vitamins and minerals [9].
In addition to energy intake reduction, PMR have been
used to increase the intake of vitamins, minerals and
proteins and thus decrease the risk of deficiencies that
are common during energy restriction diets [10,11]. Sev-
eral studies have evaluated the effectiveness of PMR to
reduce weight among obese individuals with different
results [10,12]. Most of these studies however, have been
carried out in developed populations with a low risk of
having micronutrients deficiencies.
Besides the addition of vitamins and minerals, the effect-
iveness of PMR may be improved by being used as a
vehicle for substances with a potential benefit for the
obese. Inulin is a non-digestible and non-flavored polisac-
charide with low energy content that has been shown to
have a positive effect on lipids metabolism [13-20]. A
recent meta-analysis by Brighenti [21] reviewed 15 studies
and concluded that supplementing individuals with 7 to
10 g/d of inulin reduces their serum triglycerides by 7.5%.
A reduction of triglycerides in obese patients would be
beneficial since about 36% of individuals with obesity have
high serum triglycerides [22]. It has also been suggestedthat inulin may increase the absorption of minerals such
as zinc, iron, magnesium and calcium [23].
The objective of this study was to test the efficacy of a
PMR added with vitamins, minerals and inulin on
weight reduction, blood lipids and micronutrients intake
in obese Mexican women.
Methods
Subjects and treatments
A total of 144 non-pregnant, non-lactating, overweight
or obese women (BMI ≥ 25 kg/m 2) were included in the
study. The sample size considered an alpha error of 0.05,
statistical power of 0.80 and a lost to follow up rate of
20% to detect a difference in body weight reduction of
4% between treatments and control with an estimated
standard deviation of 6%. Women were excluded if they
had been previously diagnosed with diabetes, hyperten-
sion or if they had fasting glucose ≥126 mg/dL and
blood triglycerides ≥400 mg/dL. All subjects received
oral and written information of the study protocol, in-
cluding benefits and potential risks, and voluntarily
accepted to participate in the study. The study protocol
was reviewed and approved by the Bioethics Committee
of the University of Queretaro.
The study was a randomized, controlled, longitudinal,
clinical trial. Women who accepted to participate were
randomized into one of 4 groups of 36 women each,
with a computer generated randomization list. Women
in each group received during 3 months one of the fol-
lowing treatments: 1) PMR alone; 2) PMR+ 10 g of inu-
lin (PMR+ I); 3) 10 g of inulin alone (INU) or 4) Control
group with no additional treatment (CON). In addition,
a LCD was provided to subjects in all 4 groups. The
LCD consisted of educating subjects in detail with a printed
guideline developed according with the official food guide
for Mexican population (NOM-043-SSA2-2005) and with
the National Institutes of Health guide to treat over-
weight and obese adults [24]. The guide showed the ap-
propriate proportions of the different food groups in a
meal and included a list of foods with high content of
fat and/or sugar that should be avoided and replaced by
equivalent low calorie foods (i.e. whole milk for skimmed
milk). The guide also provided suggestions to include
high fiber products and water and the size of food por-
tions to include in the diet.
The PMR was developed before the initiation of the clin-
ical trial by a pharmaceutical laboratory located in the city
of Queretaro where the study was carried out ( EsbeliaTM).
The PMR was designed to contain sufficient amounts of all
vitamins and minerals, especially those that have been
reported to be deficient in Mexicans [25]. The nutrient
composition of the PMR used in this study is shown in
Table 1. An additional version of the PMR was also devel-
oped which contained 5 g of inulin per dose; inulin was
Table 1 Nutrient composition of one dose of a partial
meal replacement (PMR) as powder and prepared with
skim milk
Nutrients PMR powder PMR Prepared with skim milk
33 g 273 g
MACRONUTRIENTS
Energy, Kj 483.79 835.25
Proteins, g 5.38 13.54
Carbohydrates, g 17.49 29.25
Lipids, g 0.40 0.78
Dietary fiber, g 0.12 0.12
MICRONUTRIENTS
Vitamins
A (Retinol), μg 199.50 345.90
D (Cholecalciferol), μg 2.50 2.50
E, mg 9.10 9.10
K, μg 26.25 26.25
C, mg 52.50 54.42
Folic Acid, μg 230.00 242.72
B1, mg 0.45 0.54
B2, mg 0.45 0.78
B6, mg 0.50 0.60
B12, μg 1.20 2.11
Niacin, mg 6.00 6.19
Biotin, μg 15.00 15.00
Pantotenic acid, mg 2.50 2.50
Minerals
Calcium, mg 180.00 475.20
Phosphorus, mg 92.74 92.74
Iodine, μg 25.00 25.00
Iron, mg 5.10 5.19
Magnesium, mg 75.00 101.40
Cupper, mg 0.22 0.22
Zinc, mg 3.30 4.26
Manganese, mg 0.54 0.54
Potassium, mg 7.70 406.10
Sodium, mg 20.69 143.09
Selenium, μg 14.40 14.40
Chromium, μg 6.60 6.60
Molybdenum, μg 13.50 13.50
PMR= Partial meal replacement
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PMR+ I were delivered to women in can containers with
400 grams of products every other week and were available
in chocolate and vanilla flavors. Women were instructed to
consume 2 servings per day of the respective treatment at
breakfast and dinner, each consisting of 33 g of powderdissolved in 250 ml of skim milk. Subjects were instructed
not to consume any additional foods for breakfast or din-
ner. Women in the INU group received two can containers
with 100 g of inulin every two weeks; they were asked to
consume one 5 g serving of inulin mixed with any drink at
breakfast and same amount at dinner (10 g of inulin/d).
The participants were followed by visits to the clinic
every two weeks and by a phone interview once every
week. During the first visit, women in the PMR, PMR+ I
and INU groups received oral and written information
explaining how to prepare the treatments and how to
follow the LCD. Women in the control group only
received the LCD. At every visit, women were asked to
bring empty cans or cans with remaining product to ex-
change for new ones. During the visits at the clinics and
during telephone calls, nutritionists reviewed the LCD
guide again with the subjects and answered any ques-
tions they might have.
Women in PMR, PMR+ I and INU treatment groups
filled an adherence log dairy to record the consumption of
treatments; they were asked to register if they consumed
or did not consume the treatment at breakfast and dinner.
Adherence to treatments was defined as the number of
days that each treatment was consumed divided by the
total number of days that each subject was followed.
Anthropometry and body composition
Weight, height, hip and waist circumference were mea-
sured at baseline and every 2 weeks during three months.
Measurements were carried out by trained nutritionists
following standard procedures [26]. Weight was measured
to the nearest 100 g using electronic scales (SECA ONDA
843, Hamburg, Germany). Height was measured with a
stadiometer (SECA 206, Hanover, MD) to the nearest
0.1 cm. Waist and hip circumference was measured to the
nearest 0.1 cm with a flexible band (SECA 200; Seca
Deutschland) following procedures recommended by
WHO [27]. Measurements on each subject on different
occasions were done by the same examiner to reduce
variability.
Body composition was determined with bioelectrical im-
pedance (Quantum X BIA, RJL Systems Inc. Clinton
Township, MI) at baseline and every month during the
three months of follow-up. Women were asked to lay
down in a quiet room and remain calmed for the duration
of the measurement. Fat percent was calculated from re-
sistance and reactance using Kotler equations [28].
Glucose and lipid profile
A fasting blood sample was taken at baseline and after
3 months to measure plasma lipids and glucose concen-
trations. Plasma glucose was determined using the
glucose oxidase method. Total serum cholesterol, HDL-
cholesterol, and triglycerides were measured using a
Figure 1 Flow-chart.
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(Johnson&Johnson Vitros DT60 II Chemistry System
Rochester, NY USA). LDL was estimated with the Frie-
dewald equations [29].
Food and nutrient intake evaluation
Food intake was assessed at baseline and after three
months using three 24-recalls, one was applied on a week-
end day and two on days of the week, Nutrient intake was
determined using food composition tables from the US
department of agriculture [30] and from the National
Institute of Medical Sciences and Nutrition [31]. Percents
of adequacy were calculated from the recommended
nutrients intake for Mexican population [32,33].
Statistical analysis
Descriptive analysis was carried out for all variables.
Within treatment change in anthropometry, body fat and
lipids concentration, by treatment group, were compared
with paired T-test; this test was used because the
independent variable has two levels (pre-treatment and
post-treatment). To evaluate the effect of treatment on
anthropometry and lipids concentration an analysis of
variance (ANOVA) adjusted for initial values was carried
out considering the change (final-initial value) as the
dependent variable. Unadjusted ANOVA to evaluate nutri-
ents intake was used to compare between treatments. All
reported p-values are based on two-sided tests and com-
pared to a significance level of 0.05. SPSS version 10 (SPSS
Inc, Chicago, IL, U.S.A.) software was used for all statis-
tical calculations.
Results
Flow diagram of participants is shown in Figure 1. The
subjects that did not finish the intervention, abandoned
the study for personal reasons not related to the treat-
ment. Characteristics of subjects by treatment group at
the beginning of the study are described in Table 2. No
differences were observed between groups in any of the
study variables at baseline or between subjects that were
lost to follow up and subjects that remained to the end
of the study.
Effect of treatments on anthropometry and body
composition
All groups significantly reduced their weight, BMI, and
waist and hip circumferences. Weight was significantly
lower from baseline value in all treatment groups since
the first post-treatment evaluation after 2wk, and weight
loss was maintained along the trial. After 90 days, weight
reduction of women in the PMR+ I, PMR, INU and
CON groups was [Mean (95%CI)]: –3.88 (−4.92, -2.84),
-4.09 (−4.97, -3.20), -2.81 (−3.68, -1.93) and −2.89
(−3.85, -1.94) Kg, respectively. There were no significantdifferences in unadjusted changes between groups. The
differences of adjusted changes found were as follows:
After 45 days a greater reduction of BMI was observed in
PMR group (mean; 95% CI) (−1.16; -1.40, -0.91 kg/m2)
compared with INU (−0.68; -0.94, -0.42) and CON
(−0.80; -1.06, -0.54) groups. At 60 days, BMI decreased
more in PMR+ I (−1.24; -1.56, -0.93) and PMR (−1.37;
-1.66, -1.08) than in INU (−0.75; -1.05, -0.44). After 75
and 90 days no differences were observed between
groups. Similarly, weight loss was greater at 45 days in
PMR group (−2.85; -3.45, -2.25Kg) compared with INU
(−1.64; -2.26, -1.01) and CON (−1.97; -2.59, -1.35)
groups. And at 60 days, weight decreased more in PMR+
I (−3.07; -3.84, -2.29) and PMR (−3.36; -4.07, -2.66) than
in INU (−1.84; -2.59, -1.10) (Figure 2). Adjusted waist cir-
cumference reduction after 60 days was 1.8 cm greater,
in PMR group (−4.87; -5.77, -3.96) compared with INU
group (−3.06; -4.02, -2.11) (Figure 3). Body fat after the
intervention was statistically similar than baseline.Effect of treatments on lipids and glucose concentration
Groups PMR+ I, PMR, INU, significantly reduced by
21.5%, 19.3% and 20% respectively, their triglycerides
concentration after 3 months of intervention (Table 3).
No other significant changes were found in lipids or glu-
cose concentrations.Food and nutrient intake
The energy, carbohydrates, protein, fat and cholesterol
intake was significantly reduced in all groups (Table 4).
Fat intake reduction was greater in PMR and PMR+ I
groups than in INU and CON groups, and fiber intake
increased more in PMR+ I and INU groups than in
PMR and CON groups. Cholesterol intake was lower in
PMR and PMR+ I groups than CON group. Protein in-
take was higher in PMR+ I and INU groups than the
CON group.
Macronutrient and micronutrient intakes as percent of
adequacy from the recommended intake by treatment
Table 2 Characteristics of subjects at baseline by treatment group1,2
PMR+ I PMR INU CON
N 23 28 30 29
Age, y 34.62 ± 7.4 33.17 ± 7.63 32.58 ± 8.13 33.39 ± 8.72
Weight, Kg 75.96 ± 11.71 75.79 ± 12.45 76.55 ± 10.96 76.45 ± 11.07
Height, cm 155.98 ± 4.45 157.32 ± 5.91 157.76 ± 5.94 157.49 ± 6.29
Waist circumference, cm 91.88 ± 9.91 90.75 ± 9.34 91.07 ± 8.66 92.16 ± 8.91
BMI (Kg/m2) 31.17 ± 4.37 30.55 ± 4.13 30.74 ± 3.87 30.86 ± 4.47
Body fat, % 38.85 ± 6.16 39.39 ± 5.43 39.45 ± 6.11 40.22 ± 6.29
Glucose, mg/dL 104.39 ± 10.3 96.66 ± 13.57 95.59 ± 7.58 97.83 ± 8.44
Total cholesterol, mg/dL 186.74 ±37.56 172.75 ± 34.36 171.00 ± 26.13 183.75 ± 24.84
HDL, mg/dL 41.74 ± 10.55 44.40 ± 10.58 41.26 ± 9.66 44.54 ± 8.44
LDL, mg/dL 110.59 ± 35.12 96.37 ± 40.76 96.72 ± 26.54 109.79 ± 22.99
Triglycerides, mg/dL 172.13 ± 71.43 159.89 ± 82.26 165.10 ± 80.22 154.03 ± 80.1
1 Values are means ± Standard deviation.
2 There were no significant differences between treatment groups in ANOVA.
PMR= Partial meal replacement, INU= Inulin, CON= Control group.
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in Table 5. Following the intervention PMR and PMR+ I
groups had a higher percent of adequacy of calcium,
iron, zinc, vitamins C, B1, B2, B6, B12 niacin and folic
acid than the CON group. Intakes of sodium, potassium,
vitamin A and B12 were similar among treatment
groups.
Discussion
Results of PMR effect on body weight have been contro-
versial. Recent revisions and meta-analysis suggest that
their use have a moderate effect resulting in weight loss
of around 9%–10% of total body weight in the short
term (3–6 months), and 6%–8% in the long term
(> 1 years), when used as part of an overall low-energyFigure 2 Body weight change by treatment group. Values are estimate
mean significant difference between treatments. PMR+ I = Partial meal repl
CON= control.diet plan [11,12,17,34]. Our results showed that the in-
clusion of PMR alone or in combination with inulin to a
LCD was equally effective to reduce weight compared to
LCD alone. After 90 days, both groups with PMR lost an
average of 4 Kg or about 5.4% of initial weight. This re-
duction was about 28% higher than the reduction with
the LCD alone but the difference was not statistically
significant. Similarly to our results Noakes [35] com-
pared a group of obese men with PMR and LCD with a
group with LCD alone and found after 3 months, a loss
of body weight of 6.6 Kg (6.9%) and 6.0 Kg (6.3%), re-
spectively. Another study in obese women found after
one year of treatment a weight reduction of 5.0 Kg
(6.2%) with PMR plus LCD and 6.1 Kg (8%) with LCD
alone; the difference was not statistically significant [10].d mean changes adjusted for the initial value. a, b Different letters
acement with inulin, PMR= Partial meal replacement, INU= Inulin,
Figure 3 Waist circumference change by treatment group. Values are estimated mean changes adjusted for the initial value. Different letters
mean significant difference between treatments. PMR= Partial meal replacement with inulin, PMR= Partial meal replacement, INU= Inulin,
CON= control group.
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weight of 7.1 kilograms after 3 months or 7.7 kilograms
after one year with the inclusion of PMR to a LCD ; but
in these studies the effect was significantly higher thanTable 3 Treatment effect on glucose and lipid profile1
Biochemical variables PMR+ I PM
N 23 28
Glucose, g/dL
Baseline 104.4 ± 10.3 96
Final 101.7 ± 13.7 93
Adjusted change2,3 −0.4 ± 9.4 −
Total cholesterol, g/dL
Baseline 186.7 ± 37.6 17
Final 176.6 ± 37.2 17
Adjusted Change 2 −6.6 ± 24.1 −
HDL, g/dL
Baseline 41.7 ± 10.5 44
Final 38.8 ± 9.1 40
Adjusted Change 2 −3.3 ± 6.6 −
LDL, g/dL
Baseline 110.6 ± 35.1 96
Final 110.7 ± 30.3 10
Adjusted Change 2 4.4 ± 22.4 8.
Triglycerides, g/dL
Baseline 172.1 ± 71.4 15
Final 135.5 ± 49.63 12
Adjusted Change 2 −30.8 ± 42.23 −
1 Values are means ± standard deviation.
2 Estimated mean adjusted for baseline value.
3 Change is different within treatment in pared T-Test, p < 0.05
No significant differences were found between treatments.
PMR= Partial meal replacement, INU= Inulin, CON= Control group.LCD mainly because the effect of LCD was very low (1.3
and 3.4 kilograms, respectively). One recent study found
a significant positive effect on weight reduction by the
inclusion of PMR to a LCD [36]. Obese subjects lost inR INU CON
30 29
.7 ± 13.6 95.6 ± 7.6 97.8 ± 8.4
.2 ± 13.3 96.0 ± 8.7 95.8 ± 7.9
4.1 ± 9.1 −0.6 ± 9.1 −2.2 ± 9.0
2.8 ± 34.4 171.0 ± 26.1 183.8 ± 24.8
4.5 ± 30.0 176.3 ± 26.7 184.6 ± 26.9
0.4 ± 24.0 2.4 ± 24.0 3.1 ± 24.0
.4 ± 10.6 41.3 ± 9.7 44.5 ± 8.4
.6 ± 9.7 41.7 ± 8.7 40.8 ± 10.1
3.4 ± 6.6 −0.1 ± 6.6 −3.3 ± 6.6
.4 ± 40.8 96.7 ± 26.5 109.8 ± 23.0
8.9 ± 25.8 108.3 ± 25.6 117.5 ± 24.0
9 ± 22.4 8.1 ± 22.4 11.5 ± 22.4
9.9 ± 82.3 165.1 ± 80.2 154.0 ± 80.1
4.9 ± 55.03 131.6 ± 57.23 133.4 ± 47.2
36.4 ± 42.23 −31.8 ± 42.23 −25.6 ± 42.2
Table 4 Macronutrients intake at baseline and during the study 1
PMR+ I PMR INU CON
N 21 26 27 28
Energy, kJ
Baseline 8,431.5 ± 2,631.0 7,865.9 ± 3,060.4 7,327.5 ± 2,233.1 7,574.6 ± 2,041.8
Final 4,624.0 ± 1,454.9 4,688.4 ± 1,487.1 5,198.8 ± 1,986.1 4,607.7 ± 1,221.6
Adjusted change2 −3,807.5 ± 2,468.7 −3,177.5 ± 3,180.0 −2,128.8 ± 2,987.5 −2,966.9 ± 2,248.4
Carbohydrates, g
Baseline 242.1 ± 75.6 247.4 ± 99.6 241.9 ± 75.4 216.0 ± 82.9
Final 144.9 ± 62.73 143.9 ± 52.93 138.9 ± 34.83 161.6 ± 75.43
Adjusted change2 −92.3 ± 57.3 −94.1 ± 57.4 −98.3 ± 57.3 −71.5 ± 57.7
Protein, g
Baseline 80.2 ± 32.6 69.6 ± 28.3 65.4 ± 24.2 71.5 ± 16.9
Final 64.0 ± 14.23 59.0 ± 11.3 64.9 ± 17.8 58.1 ± 19.53
Adjusted change2 −7.9 ± 16.4 −12.1 ± 16.2 −5.9 ± 16.3 −13.1 ± 16.2
Total fat, g
Baseline 85.0 ± 39.8 72.6 ± 36.2 67.7 ± 24.8 67.8 ± 25.6
Final 27.9 ± 12.13 31.4 ± 25.53 34.1 ± 19.13 42.3 ± 19.53
Adjusted change2 −45.6 ± 20.2 a −41.1 ± 19.9 a −38.0 ± 19.9 −29.8 ± 19.9 b
Cholesterol, mg
Baseline 264.4 ± 157.7 227.2 ± 116.4 200.3 ± 110.3 238.8 ± 101.5
Final 124.8 ± 112.43 92.1 ± 38.33 130.1 ± 66.13 198.6 ± 172.3
Adjusted change2 −112.0 ± 110.3 a −138.2 ± 109.4 a −95.4 ± 110.3 b −33.7 ± 109.4 b
Total fiber, g
Baseline 13.9 ± 5.1 14.9 ± 9.5 13.6 ± 10.4 14.6 ± 7.1
Final 17.5 ± 6.13 9.1 ± 4.03 20.83 ± 6.33 13.4 ± 5.1
Adjusted change2 3.5 ± 7.3 a −4.9 ± 7.4b 6.97 ± 7.5a −0.75 ± 7.5 b
1 Values are means ± Standard error.
2 Estimated mean adjusted for baseline value.
3 Change is different within treatment in pared T-Test, p < 0.05.
a, b Different letters represent significant differences between treatments p < 0.05.
PMR= Partial meal replacement, INU= Inulin, CON= Control group.
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compared with 6.5 kilograms (6.7%) with LCD alone
after 16 weeks. In this study, subjects had an average
BMI at the beginning of the study of 38 Kg/cm2, which
was much higher than the baseline average BMI in our
study of 31 Kg/cm2. This suggests that the inclusion of
PMR to an LCD is more effective when subjects are
“more obese”.
Treatments with PMR, PMR+ I and INU significantly
reduced triglycerides after 3 months of treatment. Both
groups with inulin and PMR alone had an effect, so this
could be attributed to inulin or its combination with a loss
of body fat. Of 11 studies reviewed by Delzenne [13] on
the effect of inulin on blood lipids, 4 studies did not find
an effect of inulin on total cholesterol and triglycerides, 3
studies showed significant reduction in triglycerides, and 5
studies showed a modest reduction in total cholesterol
and LDL cholesterol. Brighenti [21] conducted a meta-analysis that included studies and concluded that the in-
take of inulin was associated with significant decreases in
serum triglycerides of 0.17 mmol/L (15 mg/dL) or 7.5%.
Brighenti [16] found a marked reduction on plasma trigly-
cerides and moderate decrease in plasma cholesterol in
twelve healthy men consuming 9 g inulin/d. Letexier et al.
[18] observed a 16% decrease in plasma triglycerides in
eight subjects consuming 10 g inulin/d. In the present
study, a significant reduction of 21.3%, 21.9% and 20.3% of
plasma triglycerides was found with PMR+ I, PMR and
INU groups. In average, our subjects did not show ele-
vated concentration of cholesterol or triglycerides at the
beginning of the study; thus the effect that we found in re-
ducing triglycerides could be more important in obese
subjects that have high lipids concentrations as has been
reported in other studies [19,20,37] [38].
Total energy and carbohydrates intakes decreased
similarly in all groups and fat intake, including
Table 5 Percent of adequacy of recommended intake of nutrients in each treatment group at baseline and with
intervention 1
Nutrient PMR+ I PMR INU CON
Carbohydrates, % Baseline 84.2 ± 11.8 88.9 ± 12.1 90.4 ± 9.3 85.4 ± 12.5
Intervention 91.6 ± 7.8 2 90.4 ± 16.5 87.2 ± 9.9 90.0 ± 12.3
Protein, % Baseline 106.4 ± 21.3 a 100.2 ± 17.3 98.0 ± 12.5 113.9 ± 24.8 b
Intervention 163.9 ± 37.8 2, a 151.1 ± 33.3 2, a 158.2 ± 29.4 2 a 128.4 ± 23.6 2 b
Fat, % Baseline 95.4 ± 13.8 93.5 ± 14.6 92.1 ± 16.5 89.5 ± 15.6
Intervention 74.3 ± 14.7 2 73.2 ± 27.6 2 80.5 ± 15.3 2 82.4 ± 14.2
Calcium, % Baseline 98.8 ± 26.9 92.1 ± 40.4 92.7 ± 40.3 92.7 ± 29.5
Intervention 119.0 ± 20.3 2,a 118.9 ± 37.7 2 a 107.2 ± 35.8 a 83.3 ± 31.3 b
Iron, % Baseline 68.4 ± 21.7 62.0 ± 34.8 60.3 ± 27.5 54.8 ± 17.9
Intervention 71.8 ± 14.1 a 69.8 ± 14.6 a 40.7 ± 14.9 2 b 47.1 ± 16.4 b
Magnessium, % Baseline 74.9 ± 37.9 80.6 ± 42.1 75.2 ± 44.2 81.1 ± 38.7
Intervention 107.4 ± 26.7 2 a 107.2 ± 32.0 2 a 62.2 ± 22.3 b 68.7 ± 30.0 b
Sodium, % Baseline 99.6 ± 42.0 86.0 ± 48.2 90.0 ± 44.0 88.8 ± 43.7
Intervention 68.7 ± 48.6 2 63.9 ± 29.4 2 a 69.8 ± 31.9 2 85.3 ± 42.6 b
Potassium, % Baseline 47.1 ± 14.8 50.0 ± 21.3 48.4 ± 21.9 52.5 ± 10.2
Intervention 49.0 ± 13.2 46.9 ± 12.1 54.2 ± 16.3 48.1 ± 14.1
Zinc, % Baseline 47.3 ± 22.1 68.6 ± 96.8 48.4 ± 21.1 54.3 ± 21.1
Intervention 94.0 ± 25.1 2 a 92.6 ± 18.8 a 43.7 ± 19.8 b 38.5 ± 11.7 2 b
Vitamin A, % Baseline 228.7 ± 270.5 144.5 ± 91.5 175.9 ± 311.2 138.0 ± 89.0
Intervention 195.5 ± 83.9 198.9 ± 80.1 2 160.0 ± 73.4 272.3 ± 490.2
Vitamin C, % Baseline 126.5 ± 72.3 143.8 ± 144.6 102.8 ± 64.6 140.0 ± 108.7
Intervention 214.7 ± 78.5 2 a 197.7 ± 65.3 a,b 113.6 ± 61.3 c 158.7 ± 125.3 b
Vitamin B1, % Baseline 129.3 ± 53.3 123.7 ± 58.7 109.4 ± 44.3 104.3 ± 26.5
Intervention 158.6 ± 27.5 a 154.7 ± 37.0 2 a 88.5 ± 31.3 b 98.7 ± 38.3 b
Vitamin B2, % Baseline 166.8 ± 72.0 a 136.7 ± 63.3 117.8 ± 40.5 b 135.9 ± 29.8 b
Intervention 195.7 ± 35.7 a 188.5 ± 39.6 2 a 134.9 ± 49.1 b 138.3 ± 81.5 b
Niacin, % Baseline 125.0 ± 54.0 115.9 ± 47.5 104.9 ± 46.6 109.6 ± 39.4
Intervention 157.9 ± 37.7 a 164.9 ± 38.7 2 a 113.5 ± 33.9 b 102.1 ± 43.1 b
Vitamin B6, % Baseline 98.7 ± 47.7 104.3 ± 55.1 86.3 ± 33.8 101.8 ± 35.0
Intervention 163.5 ± 32.8 2 a 159.1 ± 34.6 2 a 96.2 ± 34.7 b 95.8 ± 39.6 b
Folic Acid, % Baseline 37.7 ± 13.8 38.3 ± 31.5 34.9 ± 23.0 32.5 ± 15.5
Intervention 112.0 ± 28.5 2 a 109.2 ± 27.4 2 a 35.9 ± 17.7 b 40.4 ± 17.9 b
Vitamin B12, % Baseline 290.2 ± 445.1 a 206.0 ± 281.8 120.3 ± 139.9 b 170.4 ± 274.5
Intervention 228.5 ± 98.1 195.3 ± 52.1 153.5 ± 175.1 258.3 ± 723.1
1 Values are means ± Standard deviation.
2 Change from baseline to intervention is significant within treatment in pared T-Test, p < 0.05.
a, b Different letters represent significant differences between treatments p < 0.05.
PMR= Partial meal replacement, INU= Inulin, CON= Control group.
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groups with PMR compared with INU and CON groups.
Ditschuneit [11] found similar results; PMR reduced
cholesterol intake 17% more than a group with LCD
alone and fat intake decreased significantly 48% in the
PMR group and the control group decreased 19%. Also,
Ashley [10] found a decrease in the intake of saturatedfat and cholesterol by the inclusion of PMR. As
expected, PMR+ I and INU groups significantly
increased total fiber intake from 13.9 to 17.5, and 13.6 to
20.8 g/d per day, respectively. An increase in dietary
fiber intake is highly recommended in obese subjects
[39]. These results suggest that PMR added with inulin
can contribute with a reduction in fat intake and an
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in obese individuals with a higher risk of developing
hyperlipidemia, or insulin resistance.
An important finding of this study is that PMR could
contribute to increase the intake of essential nutrients,
which is especially important during caloric restriction
and in populations that need to reduce calories but that
are at risk of having micronutrient deficiencies. In Mex-
ico for example, there is a high prevalence of obesity,
about 30% of adults and 16% of children less than
12 years are obese[4]; and in many individuals, obesity
occurs simultaneously with some micronutrient deficien-
cies [6]; prevalence of some micronutrient deficiencies
documented in Mexican adults are: 27% in zinc, 34% in
vitamin E, 34% in vitamin C, 20% in vitamin B2 and 20%
have iron deficiency [40-42]. Treatments with PMR
increased intake of vitamins and minerals compared
with LCD alone, especially calcium, iron, magnesium,
zinc, vitamin B1, B2, B6, B12, niacin, folic acid and vita-
min C and contribute to meet recommendations of such
nutrients during LCD´s . Because PMR is prepared with
skimmed milk, the groups that included PMR increased
milk and calcium intake. Calcium intake increased 20
and 30% in the PMR+ I and PMR groups, respectively.
Long term use of LCD´s have been associated with bone
resorption in obese adults due to low intake of calcium
which can lead to bone demineralization [43]. Treat-
ments with PMR increased intake of vitamins and
minerals compared with LCD alone, especially calcium,
iron, magnesium, zinc, vitamin B1, B2, B6, B12, niacin,
folic acid and vitamin C and contribute to meet recom-
mendations of such nutrients during LCD´s . Because
PMR is prepared with skimmed milk, the groups that
included PMR increased milk and calcium intake. Cal-
cium intake increased 20 and 30% in the PMR+ I and
PMR groups, respectively. Long term use of LCD´s have
been associated with bone resorption in obese adults
due to low intake of calcium which can lead to bone
demineralization [43]. This is one of the reasons why in-
take of calcium supplements and/or milk has been found
to have beneficial effects on mineralization during pro-
longed LCD´s [44,45]. Our study suggests that the use of
PMR´s could contribute to meet recommended intakes
of nutrients specially when there is need to reduce cal-
orie intake and in individuals with micronutrient
deficiencies.
As it is common in dietary intake data, there was a
considerable variability in the nutrient intake data, even
when some statistical differences were found, some
micronutrient comparisons were low powdered because
the sample size was calculated upon body weight. In
addition, the study did not find body fat change statisti-
cally different between treatments, it has been documen-
ted that other methods such as DEXA could haveprovided more accurate results [46]. Since this study was
not intended to confirm the improvement of nutrient
status, more studies are needed to evaluate if increased
nutrient intake also increases micronutrient absorption
and improves micronutrient status.
In conclusion, we found no additional effect of including
PMR or a PMR added with inulin to a calorie restricted
diet on changes in body weight, BMI or fat loss, than a
LCD alone; however, intake of PMR, PMR added with inu-
lin or inulin alone contribute to reduce plasma triglycer-
ides during calorie restriction. In addition, treatment of
obesity with LCD that includes a PMR significantly
increased intake of essential amino acids, vitamins and
minerals and contributed to meet daily recommendations.
Results of the present study are particular relevant for
populations that have increased prevalence of obesity and
that at the same time have high prevalence of micronu-
trient deficiencies. This study points out the importance
of using adequately fortified meal replacement products to
ensure nutrient adequacy during energy intake restriction
for weight loss.
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